Incyte Correlations

INCY Stock

USD 73.52 1.80 2.51%

The current 90-days correlation between Incyte and Alnylam Pharmaceuticals is 0.2 (i.e., Modest diversification). The correlation of Incyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Incyte Correlation With Market

Weak diversification

The correlation between Incyte and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Moving together with Incyte Stock

0.8	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.76	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.65	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.71	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr

Moving against Incyte Stock

0.78	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.77	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.71	NKTX	Nkarta Inc	Pair Corr
0.7	MTEM	Molecular Templates	Pair Corr
0.7	AGL	agilon health Buyout Trend	Pair Corr
0.7	TCHH	Trustcash Holdings	Pair Corr
0.69	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.62	ME	23Andme Holding	Pair Corr
0.62	TPST	Tempest Therapeutics	Pair Corr
0.6	VALN	Valneva SE ADR	Pair Corr
0.56	IPSC	Century Therapeutics	Pair Corr
0.45	BACK	IMAC Holdings	Pair Corr
0.39	A	Agilent Technologies	Pair Corr
0.37	EQ	Equillium	Pair Corr
0.83	KO	Coca Cola Aggressive Push	Pair Corr
0.8	TLK	Telkom Indonesia Tbk	Pair Corr
0.79	HYMTF	Hyundai Motor	Pair Corr
0.73	EC	Ecopetrol SA ADR	Pair Corr
0.66	WF	Woori Financial Group	Pair Corr
0.64	PG	Procter Gamble	Pair Corr
0.61	SHG	Shinhan Financial	Pair Corr
0.57	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr

Related Correlations Analysis

	ALNY	UTHR	RARE	APLS	BGNE	BMRN	IMGN	RXDX	ARWR	IONS
ALNY		0.06	0.51	-0.23	0.54	-0.01	0.08	0.17	0.08	0.09	ALNY
UTHR	0.06		-0.56	-0.44	-0.09	-0.47	0.46	0.55	0.01	-0.39	UTHR
RARE	0.51	-0.56		0.54	0.18	0.59	-0.57	-0.64	0.38	0.67	RARE
APLS	-0.23	-0.44	0.54		-0.55	0.88	-0.82	-0.93	0.76	0.87	APLS
BGNE	0.54	-0.09	0.18	-0.55		-0.29	0.23	0.48	-0.53	-0.31	BGNE
BMRN	-0.01	-0.47	0.59	0.88	-0.29		-0.89	-0.8	0.79	0.91	BMRN
IMGN	0.08	0.46	-0.57	-0.82	0.23	-0.89		0.76	-0.7	-0.88	IMGN
RXDX	0.17	0.55	-0.64	-0.93	0.48	-0.8	0.76		-0.64	-0.82	RXDX
ARWR	0.08	0.01	0.38	0.76	-0.53	0.79	-0.7	-0.64		0.82	ARWR
IONS	0.09	-0.39	0.67	0.87	-0.31	0.91	-0.88	-0.82	0.82		IONS
	ALNY	UTHR	RARE	APLS	BGNE	BMRN	IMGN	RXDX	ARWR	IONS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IONS	+ 0.91	BMRN
BMRN	+ 0.88	APLS
IONS	+ 0.87	APLS
IONS	+ 0.82	ARWR
ARWR	+ 0.79	BMRN
ARWR	+ 0.76	APLS

High negative correlations

RXDX	- 0.93	APLS
IMGN	- 0.89	BMRN
IONS	- 0.88	IMGN
IONS	- 0.82	RXDX
IMGN	- 0.82	APLS
RXDX	- 0.8	BMRN

Risk-Adjusted Indicators

There is a big difference between Incyte Stock performing well and Incyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Incyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ALNY	1.68	(0.32)	0.00	(0.14)	0.00	0.00	2.91	(3.88)	13.26
UTHR	1.20	(0.01)	0.00	0.11	1.83	(1.13)	2.89	(3.07)	9.81
RARE	1.51	(0.34)	0.00	(0.37)	0.00	0.00	2.65	(3.20)	8.73
APLS	2.39	(0.40)	0.00	(0.45)	0.00	0.00	4.31	(5.17)	15.97
BGNE	1.81	(0.05)	0.00	(0.09)	0.00	0.00	3.46	(4.40)	13.85
BMRN	1.27	(0.54)	0.00	(1.12)	0.00	0.00	1.42	(3.32)	18.88
IMGN	5.45	3.62	1.07	(0.59)	1.44	(6.91)	8.32	(4.16)	141.41
RXDX	2.40	1.24	0.50	(0.60)	0.76	(2.61)	2.76	(3.26)	70.71
ARWR	2.18	(0.58)	0.00	(0.22)	0.00	0.00	4.67	(3.86)	19.44
IONS	1.85	(0.59)	0.00	(0.54)	0.00	0.00	3.09	(4.12)	15.60

Incyte Corporate Management

Sheila JD	General VP	Profile
Thomas Tray	Chief Finance	Profile
Pamela Murphy	Vice Communications	Profile
Paula Swain	Executive Resources	Profile
Christine Chiou	Head Relations	Profile
Michael Morrissey	Executive Operations	Profile
PharmD MBA	Executive America	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC